Report Overview

The Global Brain cancer drugs market size stood at USD 1.9 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

A brain tumour occurs with the formation of abnormal cell inside the brain. Hence, there are two types of tumours, malignant or cancerous tumours, and benign tumours. Almost all types of brain tumours produce symptoms that vary depending on the part of brain involved. Symptoms include headaches, seizures, and problems with vision, vomiting, and other mental changes.

Brain cancer is slightly different from brain tumour. Brain cancer is a disease in which the cancer cells grow to form a mass cancer tissue that intervenes with other brain functions such as muscle control, sensation, memory & other body functions. Cancer cells developing from brain tissue are termed as primary brain tumours while tumours that proliferate from other body parts to the brain are termed as metastatic tumours.



Market Drivers

The market size drivers for the growth of brain cancer diagnostics are expected to propel by technological developments, improvements in diagnostics machines. Additionally, significance in the rise of brain cancer is expected to grow globally in the upcoming years. Rise in the number of cigarette smokers responsible for brain cancer has contributed to the market size. However, major restraints comprise heavy costs associated with diagnosis, low awareness levels, and lesser accessibility.